Companies that can't back up claims that their products are made in the U.S. could face hefty penalties from the Federal Trade Commission.

Doctors who pitched medical treatments to minors with gender dysphoria may have deceived them, according to the Federal Trade Commission.

Commission Chair Andrew Ferguson opened the workshop, titled "The Dangers of 'Gender-Affirming Care' for Minors," and in his remarks said that the agency will issue a request for information in the near future on gender-affirming care, emphasizing that the workshop was "not about politics."

Refusing to investigate practices of so-called gender affirming care for minors, just because one political party opposes scrutiny, is the definition of politicization, Andrew Ferguson tells workshop with detransitioners,

Sen. Elizabeth Warren and 15 other Democratic lawmakers are renewing a call for an investigation into whether 'tariff enabled price-gouging' will impact consumers in the years ahead as President Trump's trade moves ripple through the US economy.

Many companies have been accused by regulators of using imprecise labeling to induce shoppers to pay more through appeals to their patriotism.

The daylong invite-only workshop features detransitions, parents, regulators and scientific experts on puberty blockers, cross-sex hormones and surgery for gender-confused youth.

The former director of anticompetitive activity at Lina Khan’s Federal Trade Commission has taken a job co-leading the antitrust practice at Covington & Burling.